MR imaging guidance for minimally invasive procedures

Author(s):  
Terence Z. Wong ◽  
Joachim Kettenbach ◽  
Stuart G. Silverman ◽  
Richard B. Schwartz ◽  
Paul R. Morrison ◽  
...  
2014 ◽  
Vol 51 (6) ◽  
pp. 743-744
Author(s):  
T. Kamatani ◽  
T. Shirota ◽  
S. Kondo ◽  
S. Shintani

Minimally invasive procedures for treatment of disease have become increasingly popular and require specialized instruments and precise imaging guidance. We here propose a technique of minimally invasive surgery with ultrasound echo–guided procedures as a less traumatic and invasive procedure to get particulate cancellous bone and marrow from the iliac crest for cleft palate. This technique has been used successfully at our institutions. Our experience suggests that it can provide reliable ultrasound echo imaging-guided surgery.


2006 ◽  
Vol 21 (1) ◽  
pp. 61-65 ◽  
Author(s):  
S. Beutner ◽  
M. May ◽  
B. Hoschke ◽  
C. Helke ◽  
M. Lein ◽  
...  

2007 ◽  
Vol 51 (4) ◽  
pp. 1015-1022 ◽  
Author(s):  
Thomas Frede ◽  
Ahmed Hammady ◽  
Jan Klein ◽  
Dogu Teber ◽  
Noriyuki Inaki ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Kelly E. Diaz ◽  
Douglas Tremblay ◽  
Begum Ozturk ◽  
Ghideon Ezaz ◽  
Suzanne Arinsburg ◽  
...  

2011 ◽  
Vol 24 (4) ◽  
pp. 374-385 ◽  
Author(s):  
Susan W. Miller ◽  
Mindi S. Miller

Urinary incontinence (UI) and benign prostatic hyperplasia (BPH) are 2 common urogenital problems in men. UI is associated with involuntary leakage of urine and lower urinary tract symptoms (LUTS) of urgency, frequency, and nocturia. Types of UI include functional, urge, stress, and overflow. Treatment for UI is based on the type of incontinence, patient-specific factors, and treatment preferences of both patients and health care providers. Options for the management of UI include environmental modifications, disposable incontinence products, pelvic floor exercises, pharmacotherapy, surgically implanted devices, and intermittent catheterization. BPH may be also associated with LUTS. Patient symptoms, assessed with a measurement tool such as the American Urological Association Symptom Index (AUASI), serve as the basis for determining treatment. Management approaches for BPH include pharmacotherapy, surgery, and minimally invasive procedures. Anticholinergic drugs as well as α-receptor antagonists and 5-α reductase inhibitors, either alone or in combination, are effective and useful for LUTS unresponsive to traditional pharmacotherapy. Transurethral resection of the prostate (TURP) can eliminate symptoms of BPH but is associated with relatively more complications than other available surgical and minimally invasive procedures.


Sign in / Sign up

Export Citation Format

Share Document